Medical Affairs Insights White Paper

In 2022, inPhronesis surveyed senior Medical Affairs leaders across small, medium, and large pharma and biotech companies to understand how well their teams were gathering, analyzing, and sharing scientific intelligence. The findings pointed to a gap that most organizations recognize but few have systematically addressed: the distance between having data and knowing what to do with it.

One of the clearest signals from the survey was the near-universal experience of information overload. Every single respondent agreed that, at some point, their team faces more incoming data than they have the time or bandwidth to properly analyze and translate into meaningful insights. This is not a resourcing problem in the conventional sense. Medical Affairs teams are staffed with highly trained scientific professionals. The issue is that those professionals are spending a disproportionate share of their time on administrative and organizational tasks rather than on the scientific thinking that drives value. The whitepaper explores where that time goes and why the problem tends to persist even in well-resourced organizations.

A related theme that runs throughout the survey is the challenge of appropriate knowledge sharing. Respondents described a recurring tension between the need to move information quickly across functions and the compliance obligations that govern what can be shared, with whom, and in what form. Within Medical Affairs itself, the data revealed that siloed structures are common, even where teams believe they are communicating effectively. Senior leadership, Field Medical, Medical Communications, and Medical Information often operate with different versions of the same picture, and the mechanisms for reconciling those versions are frequently informal, inconsistent, or dependent on a few key individuals.

Conference coverage emerged as one of the most instructive use cases in the paper. Managing a major medical congress involves coordinating schedules across multiple attendees, capturing real-time intelligence from presentations, posters, and KOL interactions, and then synthesizing those inputs into something useful for leadership and cross-functional stakeholders. Respondents were candid about how time-consuming this process is and how much room for improvement exists in their current workflows. The whitepaper details how these challenges play out in practice and what a more structured approach to conference intelligence management can look like.

The second half of the paper turns to solutions. inPhronesis presents its inVision Knowledge Management System as a purpose-built response to the specific needs of Medical Affairs teams, designed to centralize information, enforce appropriate access controls, and reduce the administrative burden that currently absorbs so much of the function’s capacity. The platform addresses knowledge management across three core areas: the ongoing organization of clinical and therapeutic landscape data, the management of conference and congress intelligence, and the visualization of competitive and pipeline information in formats that are immediately useful to decision-makers. The whitepaper walks through how each of these capabilities is designed to fit into existing workflows rather than replace them.

For Medical Affairs leaders thinking seriously about where their teams’ time and attention are going, this paper offers a grounded starting point, backed by the perspectives of peers who are navigating the same challenges. Download the full whitepaper for the complete survey findings, a deeper look at the inVision solution, and a practical framework for thinking about knowledge management as a strategic capability within Medical Affairs.

Please register below to access the full content

Member Sign in

Access your saved articles, exclusive insights, and personalized recommendations.

Welcome back, your personalized
learning experience awaits.

Gain full access to exclusive resources, webinars, and insights designed to help you grow and stay ahead.

Stay informed. Stay connected. Stay ahead.

Doug Foster, COO of inThought Labs, drives inVision’s growth with AI/ML innovation. MIT graduate with experience in startups, consulting, and global learning leadership at InterSystems and Boston Scientific.

Related Resources

Having worked closely with Medical Affairs and MSL teams across hundreds of scientific congresses —

The panel discussed the decision-making process for one specific aspect of drug discovery – the

Over the past two decades, the inThought team has worked closely with Medical Affairs and

Contact us

Learn how inThought Labs can simplify your life and empower your team with expert consultants and our cloud-based system, inVision.

Chris Martin

President

As the president of inThought Labs, Chris is focused on constantly improving inVision, the leading competitive and market intelligence platform for the biopharmaceutical industry, to better meet the changing needs of clients.

 

With 20 years of experience in roles being a consumer of market and competitive information, Chris understands the needs and priorities of clients. Chris was a senior principal and co-founder of inThought, a life science consulting, market research, and analytics firm. Collaborating with Ben Weintraub, Chris also co-founded BiotechTracker, an online tool for investors and precursor to inVision. Previous to inThought, he was a healthcare analyst and co-portfolio manager at two investment firms. Chris served in health care policy roles at the White House Office of Management and Budget. These roles included Medicare Desk Officer at the Office of Information and Regulatory Affairs, where he was responsible for providing recommendations to senior White House policy officials on healthcare policies and regulations.

 

Chris has a Master in Business Administration from Harvard Business School, a Master in Engineering from Villanova University, and a Bachelor of Science in Engineering from Cornell University. Prior to attending Harvard Business School, Chris served on two U.S. Navy nuclear submarines and at the Pentagon.